Alexander Szyroki

USPTO Granted Patents = 9 (Patent Applications = 8)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 9.8

ph-index = 5

Forward Citations = 78(Granted Patents)

Location History:

Ghent, BE (2014 - 2015)
Oldenburg, DE (2016 - 2023)
Goldenstedt, DE (2020 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12006352 - Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains (2024-06-11),

2. 11644471 - Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains (2023-05-09),

3. 11192938 - Serum albumin binding proteins containing immunoglobulin single variable domains (2021-12-07),

4. 11192937 - Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains (2021-12-07),

5. 10858418 - Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains (2020-12-08),

6. 9683045 - Biological materials related to c-Met (2017-06-20),

7. 9346884 - Biological materials related to c-Met (2016-05-24),

8. 9193780 - Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases (2015-11-24),

9. 8703135 - Biological materials related to c-Met (2014-04-22),

Title: Innovations and Contributions of Alexander Szyroki

Introduction

Alexander Szyroki is a notable inventor based in Oldenburg, Germany. He has made significant contributions to the field of immunology, particularly in the development of techniques for predicting and reducing protein interference in assays. With a total of nine patents to his name, Szyroki's work has had a profound impact on the accuracy and reliability of immunoassays.

Latest Patents

One of Szyroki's latest patents focuses on techniques for predicting, detecting, and reducing aspecific protein interference in assays involving immunoglobulin single variable domains. This invention provides assays that can predict whether a given immunoglobulin single variable domain (ISV) will be subject to protein interference. It also offers methods to select ISVs that are less prone to such interference and to guide modifications that can reduce this tendency. The patent outlines various approaches to improve ISVs, ensuring they have a lower likelihood of generating aspecific signals in assays.

Career Highlights

Throughout his career, Szyroki has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Ablynx N.V. and Sanofi, where he contributed to innovative research and development projects. His expertise in immunology and assay development has positioned him as a valuable asset in these organizations.

Collaborations

Szyroki has collaborated with esteemed colleagues, including Gerald Beste and Guy Hermans. These partnerships have fostered a collaborative environment that has led to advancements in the field of immunology and assay technology.

Conclusion

Alexander Szyroki's contributions to the field of immunology through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of more accurate and reliable immunoassays, showcasing the impact of his inventions on scientific research and healthcare.

This text is generated by artificial intelligence and may not be accurate.